Why Are Tandem Diabetes Shares Gaining Today?
Portfolio Pulse from Vandana Singh
Tandem Diabetes Care Inc (NASDAQ:TNDM) shares are trading higher after the company received FDA approval for the Tandem Mobi insulin pump for people with diabetes age 6 and up. The Tandem Mobi is fully controllable from a mobile app and is the world's smallest durable automated insulin delivery system. A limited release of Tandem Mobi is expected to start in late 2023, with full commercial availability planned in early 2024.
July 11, 2023 | 6:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tandem Diabetes Care's stock is trading higher due to FDA approval for its new insulin pump. This could potentially increase the company's market share and revenues in the future.
The FDA approval for Tandem Diabetes Care's new insulin pump is a positive development for the company. This could potentially increase the company's market share and revenues in the future, which is why the stock is trading higher.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100